The folks at Moody’s Investors Service, the big credit-rating agency, took a look at the impact of reimbursement cuts in the federal health-care law could have on the companies it covers. And they found that the cuts could pose an enormous credit risk for some health-care companies. See the Dow Jones Newswires story here.
via blogs.wsj.com
Home health, oxygen, DME, hospice, nursing homes are all targets for cuts.